1 suspended. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Suspended 1 |
Follow Revogenex, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) 0.075 mg RVX-100, 0.125 mg RVX-100, 0.250 mg RVX-100 - Irritable Bowel Syndrome | Phase 2 | Suspended | Revogenex, Inc. | 192 | 2010-03-01 | 2010-07-19 |
Abdominal Pain (1) · Diarrhea (1) · Irritable Bowel Syndrome (1)
Sugars (1)
United States (1)